RecruitingNot ApplicableNCT07742228

SCENAR Therapy in Chronic Non-specific Neck Pain

Assessment of the Efficacy of SCENAR Therapy in the Management of Chronic Non-specific Neck Pain


Sponsor

Hopital Foch

Enrollment

76 participants

Start Date

Mar 11, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Shifting away from a medication-centered approach is a major public health priority, particularly in chronic pain management, where non-pharmacological therapies are recommended despite barriers such as limited evidence and low prescriber awareness. SCENAR (Self-Controlled Energo-Neuro Adaptive Regulation), an electrotherapy device, lacks robust randomized controlled trial data. A prior study showed effects in both active and placebo groups after a single session, supporting further investigation. This study aims to assess whether repeated SCENAR sessions improve disability, mobility, and pain in patients with chronic neck pain.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria6

  • Male or female participants aged 18 years or older
  • Patients with chronic non-specific cervical spine pain, including cervicobrachial neuralgia, persisting for at least 3 months, with no identifiable underlying cause requiring specific treatment.
  • Patients who attended a pain clinic consultation or were referred to a pain specialist during hospitalization.
  • Neck Disability Index (NDI) score of at least 30% (≥15 points).
  • Written informed consent provided prior to study participation.
  • Patient affiliated to a national health insurance

Exclusion Criteria9

  • Pregnant women
  • Skin conditions preventing SCENAR use (wounds, recent scars, skin infections)
  • Initiation or change of analgesic treatment within 15 days prior to inclusion or during the study
  • Cervical pain related to inflammatory (spondyloarthropathy, rheumatoid arthritis, chondrocalcinosis), traumatic (fractures, dislocations), tumor-related (metastases, myeloma), infectious (spondylodiscitis), or neurological (intramedullary or posterior fossa tumor) causes
  • Previous SCENAR or ECOMODYN session
  • Implanted pacemaker or defibrillator
  • Inability to understand French
  • Adults under legal protection
  • Individuals deprived of liberty or under guardianship

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActive SCENAR device therapy

The session consists of applying the SCENAR device to the neck and surrounding cervical muscles.The device will be moved over the painful cervical area, with intensity adjusted according to patient feedback, in non-invasive sessions typically lasting 20 minutes.

DEVICESham SCENAR device Therapy

The SCENAR device will be applied to the painful cervical area without deliver electrical impulses.


Locations(1)

Hôpital Foch

Suresnes, Île-de-France Region, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07742228


Related Trials